Emma Reeve - 08 Sep 2021 Form 4 Insider Report for Aadi Bioscience, Inc. (AADI)

Role
Director
Signature
/s/ Lance Thibault, as Attorney-in-Fact
Issuer symbol
AADI
Transactions as of
08 Sep 2021
Transactions value $
$0
Form type
4
Filing time
10 Sep 2021, 16:47:09 UTC
Previous filing
08 Sep 2021
Next filing
11 Jan 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AADI Stock option (right to buy) Award $0 +16,486 $0 16,486 08 Sep 2021 Common Stock 16,486 $27.67 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, the Initial Award is scheduled to vest as to one thirty-sixth (1/36th) of the shares of common stock subject to the Initial Award on a monthly basis following the grant date on the same day of the month as the grant date (and if there is no corresponding day, on the last day of the month) such that all shares of common stock subject to the Initial Award shall be fully vested on the three year anniversary of the grant date. The grant date is September 8, 2021.